Skip to main content
. 2018 Jan 31;15(4):5175–5180. doi: 10.3892/ol.2018.7912

Table II.

Clinical patient characteristics according to positive/negative p53, TAp73 and VASH1 expression.

p53 TAp73 VASH1



Feature Negative N=79% (n) Positive N=27% (n) P-value Negative N=62% (n) Positive N=44% (n) P-value Negative N=60% (n) Positive N=46% (n) P-value
Mean (±SD) 64.8 (9.1) 61.6 (11.2) 0.140b 63.5 (9.6) 64.0 (10.0) 0.594b 65.1 (9.4) 62.4 (10.3) 0.161b
Median age
  ≤60 32.9 (26/79) 44.4 (12/27) 37.1 (23/62) 34.1 (15/44) 30.0 (18/60) 43.5 (20/46)
  >60 67.1 (53/79) 55.6 (15/27) 0.281a 62.9 (39/62) 65.9 (29/44) 0.751a 70.0 (42/60) 56.5 (26/46) 0.152a
Sex
  Male 50.6 (40/79) 59.3 (16/27) 51.6 (32/62) 54.5 (24/44) 51.7 (31/60) 54.3 (25/46)
  Female 49.4 (39/79) 40.7 (11/27) 0.438a 48.4 (30/62) 45.5 (20/44) 0.766a 48.3 (29/60) 45.7 (21/46) 0.784a
Smoking
  Non-smoker 53.2 (42/79) 66.7 (18/27) 56.5 (35/62) 56.8 (25/44) 61.7 (37/60) 50.0 (23/46)
  Smoker 46.8 (37/79) 33.3 (9/27) 0.222a 43.5 (27/62) 43.2 (19/44) 0.970a 38.3 (23/60) 50.0 (23/46) 0.230a
Histological type
  Adenocarcinoma 35.4 (28/79) 92.6 (25/27) 16.1 (10/62) 97.7 (43/44) 36.7 (22/60) 67.4 (31/46)
  Paraneoplastic 64.6 (51/79) 7.4 (2/27) <0.001a 83.9 (52/62) 2.3 (1/44) <0.001a 63.3 (38/60) 32.6 (15/46) 0.002a
Disease stage
  I 0 (0/28) 4.0 (1/25) 0.339a 0 (0/10) 2.3 (1/43) 0.431a 0 (0/22) 3.2 (1/31) 0.695a
  I–II 3.6 (1/28) 0 (0/25) 0 (0/10) 2.3 (1/43) 0 (0/22) 3.2 (1/31)
  II 78.6 (22/28) 72.8 (18/25) 6.0 (6/10) 79.1 (34/43) 81.8 (18/22) 71.0 (22/31)
  II–III 7.1 (2/28) 20.0 (5/25) 2.0 (2/10) 11.6 (5/43) 9.1 (2/22) 16.1 (5/31)
  III 10.7 (3/28) 4.0 (1/25) 2.0 (2/10) 4.7 (2/43) 9.1 (2/22) 6.5 (2/31)
a

Chi-squared P-value.

b

Student's t-test P-value. Score ≤3 indicates negative expression; score >3 indicates positive expression; SD, standard deviation; I, well-differentiated adenocarcinoma; II, moderately-differentiated adenocarcinoma; III, poorly-differentiated adenocarcinoma; VASH1, vasohibin-1.